Frédéric Moisan

Frédéric Moisan

Auto-generated profile, based on publicly available information

Frédéric Moisan

Département santé travail, Institut de veille sanitaire (InVS), Saint-Maurice, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Revue Neurologique
Verified
Journal Article
Closed access
AEA. Elbaz
A. Elbaz
LCL. Carcaillon
L. Carcaillon
SKS. Kab
S. Kab
FMF. Moisan
F. Moisan

1 June 2009 in Toxicology
Verified
Journal Article
Closed access
SHSalik Hussain
Salik Hussain
SBSonja Boland
Sonja Boland
ABArmelle Baeza-Squiban
Armelle Baeza-Squiban
Rodolphe HamelRodolphe Hamel
Rodolphe Hamel
LTLeen C. J. Thomassen
Leen C. J. Thomassen
FMFrancelyne Marano
Francelyne Marano

13 April 2009 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
AEAlexis Elbaz
Alexis Elbaz
JCJacqueline Clavel
Jacqueline Clavel
PRPaul J. Rathouz
Paul J. Rathouz
FMFrédéric Moisan
Frédéric Moisan
JGJean‐Philippe Galanaud
Jean‐Philippe Galanaud
CTChristophe Tzourio
Christophe Tzourio

23 December 2015 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
FMFrédéric Moisan
Frédéric Moisan
SKSofiane Kab
Sofiane Kab
FMFatima Mohamed
Fatima Mohamed
MCMarianne Canonico
Marianne Canonico
MGMorgane Le Guern
Morgane Le Guern
AEAlexis Elbaz
Alexis Elbaz
Background Parkinson’s disease (PD) is 1.5 times more frequent in men than women. Whether age modifies this ratio is unclear. We examined whether male-to-female (M–F) ratios change with age through a French nationwide prevalence/incidence study (2010) and a meta-analysis of incidence studies. Methods We used French national drug claims databases to identify PD cases using a validated algorithm. We computed M–F prevalence/incidence ratios overall and by age using Poisson regression. Ratios were regressed on age to estimate their annual change. We identified all PD incidence studies with age/sex-specific data, and performed a meta-analysis of M–F ratios. Results On the basis of 149 672 prevalent (50% women) and 25 438 incident (49% women) cases, age-standardised rates were higher in men (prevalence=2.865/1000; incidence=0.490/1000 person-years) than women (prevalence=1.934/1000; incidence=0.328/1000 person-years). The overall M–F ratio was 1.48 for prevalence and 1.49 for incidence. Prevalence and incidence M–F ratios increased by 0.05 and 0.14, respectively, per 10 years of age. Incidence was similar in men and women under 50 years (M–F ratio 0.20), and over 1.6 (p<0.001) times higher in men than women above 80 years (p trend <0.001). A meta-analysis of 22 incidence studies (14 126 cases, 46% women) confirmed that M– F ratios increased with age (0.26 per 10 years, p trend=0.005). Conclusions Age-increasing M–F ratios suggest that PD aetiology changes with age. Sex-related risk/protective factors may play a different role across the continuum of age at onset. This finding may inform aetiological PD research.

1 January 2008 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
BLBéatrice L'Azou
Béatrice L'Azou
JJJoana Jorly
Joana Jorly
DODinhill On
Dinhill On
ESElisabeth Sellier
Elisabeth Sellier
FMFrédéric Moisan
Frédéric Moisan
COCéline Ohayon-Courtès
Céline Ohayon-Courtès
The ability of nanoparticles to cross the lung-blood barrier suggests that they may translocate to blood and to targets distant from their portal of entry. Nevertheless, nanotoxicity in organs has received little attention. The purpose of this study was to evaluate nanotoxicity in renal cells using in vitro models. Various carbon black (CB) (FW2–13 nm, Printex60-21 nm and LB101-95 nm) and titanium dioxide (TiO2-15 and TiO2-50 nm) nanoparticles were characterized on size by electron microscopy. We evaluated theirs effects on glomerular mesangial (IP15) and epithelial proximal tubular (LLC-PK1) renal cells, using light microscopy, WST-1 assay, immunofluorescence labeling and DCFH-DA for reactive oxygen species (ROS) assay.

1 August 2008 in Current Opinion in Neurology
Verified
Journal Article
Closed access
AEAlexis Elbaz
Alexis Elbaz
FMFrédéric Moisan
Frédéric Moisan
In the past 18 months, several important studies on the epidemiology of Parkinson's disease have been published. In particular, large cohorts have identified sufficient incident patients with Parkinson's disease to study risk or protective factors of Parkinson's disease; one of the important recent events in the field is the publication of some of their findings. We will first review findings of descriptive studies on the frequency of the disease and its geographic or temporal distribution. We will then summarize the findings of analytical studies dealing with risk or protective factors in the fields of dietary and lifestyle factors (cigarette smoking, coffee and tea drinking, uric acid, dairy products), environmental exposures (pesticides, lead, manganese, welding), hormonal factors (oophorectomy), vascular risk factors (diabetes, hypertension, cholesterol level), pharmacoepidemiology (NSAIDs, statins), and familial aggregation. Epidemiologic studies have consistently found that some exposures are inversely (e.g., cigarette smoking) or positively associated with Parkinson's disease (e.g., pesticides), while their findings are, at the present time, less consistent for other exposures (e.g., NSAIDs, vascular risk factors). Finally, recent studies have investigated new research fields (e.g., hormonal factors, uric acid, pharmacoepidemiology) and additional data need to be collected.